|Bid||40.18 x 3200|
|Ask||40.20 x 3000|
|Day's range||39.97 - 40.62|
|52-week range||39.23 - 56.32|
|Beta (5Y monthly)||0.58|
|PE ratio (TTM)||23.56|
|Earnings date||01 May 2023 - 05 May 2023|
|Forward dividend & yield||1.64 (3.76%)|
|Ex-dividend date||26 Jan 2023|
|1y target est||52.81|
In the latest trading session, Pfizer (PFE) closed at $40.22, marking a -0.42% move from the previous day.
Whether it's bear markets, shifting legislation, or an unstable macroeconomic environment, there are plenty of reasons an otherwise-stable company might see its stock stumble temporarily. Pfizer's (NYSE: PFE) shares are down by 20.3% in the last 12 months, and if you're willing to hold on to them for the long run, this stock is a great option for buying on the dip to gain a passive income stream.
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.